Suzana Assad Kahn
|Neurosurgery||Stanford University School of Medicine, Palo Alto, CA, United States|
Area:Immuno-oncology, Myeloid cells, Brain tumors, Stem cell biology, Neuroscience
Google:"Suzana Assad Kahn"
Kahn, a postdoctoral scholar, was one of 10 researchers named 2012 Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts. The fellowship, established in 1991, provides $30,000 salary support in each of two years for postdoctoral-level, Latin American scientists to work in top laboratories in the United States. Upon completion of the U.S.-based research, fellows returning to Latin America to establish labs in their home countries receive an additional $35,000 in funding. Kahn, from Brazil, studies cancer cell biology in the lab of Irving Weissman, PhD, director of the Institute for Stem Cell Biology and Regenerative Medicine. Her work attempts to isolate and characterize cells that initiate cancer in the brain.
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Kahn SA, Wang X, Nitta RT, et al. (2018) Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651|
|Kahn SA, Wang X, Nitta RT, et al. (2018) Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121|
|Dos Santos Cavalcanti A, Meohas W, Ribeiro GO, et al. (2017) Patient-derived osteosarcoma cells are resistant to methotrexate. Plos One. 12: e0184891|
|Gholamin S, Mitra SS, Feroze AH, et al. (2017) Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9|
|Zhang M, Hutter G, Kahn SA, et al. (2016) Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. Plos One. 11: e0153550|
|Mitra SS, Feroze AH, Gholamin S, et al. (2015) Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells. Neurosurgery|